carbamates has been researched along with Carcinoma, Ductal, Breast in 1 studies
Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
Excerpt | Relevance | Reference |
---|---|---|
"These included acute lymphoblastic leukemia (ALL) and human breast cancer (BC) derived from two different tumor subtypes, ER+ invasive ductal carcinoma grade III (IDCG3) and metastatic carcinoma (MC)." | 1.56 | Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study. ( Chambers, TC; Huczyński, A; Jousheghany, F; Klejborowska, G; Majcher-Uchańska, U; Monzavi-Karbassi, B; Moorjani, A; Piña-Oviedo, S; Urbaniak, A; Yuan, Y, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Urbaniak, A | 1 |
Jousheghany, F | 1 |
Piña-Oviedo, S | 1 |
Yuan, Y | 1 |
Majcher-Uchańska, U | 1 |
Klejborowska, G | 1 |
Moorjani, A | 1 |
Monzavi-Karbassi, B | 1 |
Huczyński, A | 1 |
Chambers, TC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Single-center Clinical Trial to Evaluate the Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients[NCT05802992] | Phase 3 | 30 participants (Anticipated) | Interventional | 2022-03-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for carbamates and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carbamates; Carcinoma, Ductal, Breast; Cell Proliferat | 2020 |